Mobile

Pilot study on safety of four weekly administrations of 7 mg/kg of liposomal amphotericin B (AmBisome®) in antifungal primary prophylaxis treatment of elderly patients with acute lymphoblastic leukemi...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004495-21

Pilot study on safety of four weekly administrations of 7 mg/kg of liposomal amphotericin B (AmBisome®) in antifungal primary prophylaxis treatment of elderly patients with acute lymphoblastic leukemia undergoing induction chemotherapy within the GMALL-Elderly protocol

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To characterize the safety profile of a prophylactic antifungal LAMB treatment of 7 mg/kg, administered as a weekly intravenous infusions over two hours, during induction treatment of acute lymphoblastic leukemia of elderly patients undergoing chemotherapy with GMALL-Elderly 1/2003 protocol for four weeks.

Critère d'inclusion

  • Antifungal prophylaxis

Liens